Ftse Mib
35.687,84
1,60%
DAX
20.574,68
1,55%
S&P 500
5.949,91
1,83%
NASDAQ
19.511,23
2,45%
Bitcoin
100.079,92
3,71%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Pliant Therapeutics Inc (PLRX) Pliant Therapeutics Inc (PLRX) Notizie

PLRX

Pliant Therapeutics (PLRX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PLRX
DataOraFonteTitoloSimboloCompagnia
02/01/202514:00GlobeNewswire Inc.Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PLRXPliant Therapeutics Inc
21/11/202414:00GlobeNewswire Inc.Pliant Therapeutics to Participate in Upcoming Investor EventsNASDAQ:PLRXPliant Therapeutics Inc
19/11/202400:00GlobeNewswire Inc.Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024NASDAQ:PLRXPliant Therapeutics Inc
14/11/202423:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PLRXPliant Therapeutics Inc
07/11/202422:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLRXPliant Therapeutics Inc
07/11/202422:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
07/11/202422:05GlobeNewswire Inc.Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:PLRXPliant Therapeutics Inc
06/11/202414:00GlobeNewswire Inc.Pliant Therapeutics to Participate in the Stifel Healthcare ConferenceNASDAQ:PLRXPliant Therapeutics Inc
17/10/202414:00GlobeNewswire Inc.Pliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in a Late-Breaking Presentation at The Liver Meeting® 2024NASDAQ:PLRXPliant Therapeutics Inc
04/10/202423:34Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PLRXPliant Therapeutics Inc
01/10/202422:35GlobeNewswire Inc.Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical AffairsNASDAQ:PLRXPliant Therapeutics Inc
30/09/202422:45GlobeNewswire Inc.Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PLRXPliant Therapeutics Inc
24/09/202414:00GlobeNewswire Inc.Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical OfficerNASDAQ:PLRXPliant Therapeutics Inc
10/09/202414:00GlobeNewswire Inc.Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024NASDAQ:PLRXPliant Therapeutics Inc
28/08/202414:00GlobeNewswire Inc.Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of DirectorsNASDAQ:PLRXPliant Therapeutics Inc
26/08/202415:10GlobeNewswire Inc.Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024NASDAQ:PLRXPliant Therapeutics Inc
07/08/202422:05GlobeNewswire Inc.Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:PLRXPliant Therapeutics Inc
06/08/202422:03GlobeNewswire Inc.Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:PLRXPliant Therapeutics Inc
15/07/202414:00GlobeNewswire Inc.Pliant Therapeutics Announces Positive Long-Term Data from the INTEGRIS-PSC Phase 2a Trial Demonstrating Bexotegrast was Well Tolerated at 320 mg with Continued Antifibrotic and Anti-Cholestatic Activity Displayed Across Multiple MeasuresNASDAQ:PLRXPliant Therapeutics Inc
13/07/202400:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
13/06/202422:05GlobeNewswire Inc.Pliant Therapeutics Announces Appointment of Steve Krognes to Board of DirectorsNASDAQ:PLRXPliant Therapeutics Inc
06/06/202414:00GlobeNewswire Inc.Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™NASDAQ:PLRXPliant Therapeutics Inc
22/05/202400:50GlobeNewswire Inc.Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International ConferenceNASDAQ:PLRXPliant Therapeutics Inc
14/05/202413:30GlobeNewswire Inc.Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary FibrosisNASDAQ:PLRXPliant Therapeutics Inc
07/05/202414:00GlobeNewswire Inc.Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™NASDAQ:PLRXPliant Therapeutics Inc
06/05/202422:05GlobeNewswire Inc.Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:PLRXPliant Therapeutics Inc
27/03/202415:23GlobeNewswire Inc.Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International ConferenceNASDAQ:PLRXPliant Therapeutics Inc
12/03/202412:30GlobeNewswire Inc.Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary FibrosisNASDAQ:PLRXPliant Therapeutics Inc
27/02/202422:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PLRXPliant Therapeutics Inc
27/02/202422:03GlobeNewswire Inc.Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial ResultsNASDAQ:PLRXPliant Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PLRX

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
SPM
Saipem
BIT
IVG
Iveco Group NV
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
NEXI
Nexi S.p.A
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
STMMI
ST Microelectronics
BIT
TIT
Telecom Italia
BIT
BAMI
Banco BPM
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network